Rhesus Angiotensin Converting Enzyme 2 Supports Entry of Severe Acute Respiratory Syndrome Coronavirus in Chinese Macaques
Overview
Affiliations
Angiotensin converting enzyme 2 (ACE2) is the receptor that severe acute respiratory syndrome coronavirus (SARS-CoV) utilizes for target cell entry and, therefore, plays an important role in SARS pathogenesis. Since Chinese rhesus (rh) macaques do not usually develop SARS after SARS-CoV infection, it has been suggested that rh-ACE2 probably does not support viral entry efficiently. To determine the role of rh-ACE2 in early lung pathogenesis in vivo, we studied eleven Chinese rhesus monkeys experimentally infected with a pathogenic SARS-CoV(PUMC01) strain. Rh-ACE2 genes were amplified from all animals by reverse transcription polymerase chain reaction, and their function was studied in vitro using a pseudovirus entry assay. Many natural non-synonymous (NS) changes were found in rh-ACE2 genes. Compared to human (hu) ACE2, thirty-eight consensus NS changes were found in rh-ACE2. Since these changes do not interact with the receptor binding domain of SARS-CoV, rh-ACE2 in general is as effective as human homolog in supporting viral entry. Rh-ACE2, however, is more polymorphic than hu-ACE2. Additional sporadic NS substitutions in clone Rh11-7 reduced the level of rh-ACE2 protein expression and did not support viral entry effectively. Further mutagenesis analysis showed that a natural mutation Y217N dramatically alters ACE2 expression and entry efficiency. Moreover, introduction of the Y217N mutation into hu-ACE2 caused the down-regulation of expression and reduced viral entry efficiency. These results indicate that the Y217N mutation plays a role in modulating SARS-CoV infection. Our results provide insights for understanding the role of rh-ACE2 in SARS lung pathogenesis in a non-human primate model.
Pelajo-Machado M, da Silva A, Rodrigues D, Paiva M, Muller R, da Costa L Mem Inst Oswaldo Cruz. 2024; 119:e240100.
PMID: 39442103 PMC: 11493349. DOI: 10.1590/0074-02760240100.
COVID-19 susceptibility: potential of polymorphisms.
Chaudhary M Egypt J Med Hum Genet. 2024; 21(1):54.
PMID: 38624559 PMC: 7502288. DOI: 10.1186/s43042-020-00099-9.
Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations.
Raghav P, Raghav A, Lathwal A, Saxena A, Mann Z, Sengar M Sci Rep. 2023; 13(1):2351.
PMID: 36759535 PMC: 9910265. DOI: 10.1038/s41598-022-20773-9.
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.
Pinto M, da Silva A, Rodrigues D, Muller R, de Vasconcelos G, Neves P Mem Inst Oswaldo Cruz. 2023; 117:e220239.
PMID: 36700583 PMC: 9870265. DOI: 10.1590/0074-02760220239.
Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity.
Cao T, Liu L, To K, Lim C, Zhou R, Ming Y Clin Transl Med. 2022; 12(9):e1025.
PMID: 36103567 PMC: 9473490. DOI: 10.1002/ctm2.1025.